2m 2m 2m 2m 2m 2m 2m
CRTV MDCL HLD (CELZ)
NASDAQ
$1.32+$0.005 (+0.38%)
Price as of Aug 21, 2026 7:59 PM EDT- $8.6MMarket Cap
- -58.93%1-Year Change
- BiotechnologyIndustry
CRTV MDCL HLD (CELZ)
$1.32+$0.005 (+0.38%)
CELZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.31 | ||
Change | +$0.03 (+2.34%) | ||
Open | $1.27 | ||
High | $1.35 | ||
Low | $1.22 | ||
Previous Close | $1.28 | ||
Volume | 549,053 | ||
30-Day Average Volume | 17,546,589 | ||
1-Week Change | 7.38% | ||
1-Month Change | 57.66% | ||
1-Year Change | -58.93% | ||
3-Year Change | -72.30% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 6.6M | ||
Total Assets | $9.4M | ||
Market Cap | $8.6M | ||
Enterprise Value | -$77,866.00 | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$1.5M | ||
Free Cash Flow | -$1.5M | ||
EBIT | -$1.5M | ||
EBITDA | -$1.5M | ||
Net Working Capital | $8.3M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/12/2023 | ||
Earnings & Revenue